Sorafenib as a safe bridge to immunotherapy in patients with FLT3-ITD relapsed AML after allogeneic HSCT: a single center experience in 14 patients
Abstract
Publication Date:
2015
Iris type:
1.5 Abstract in rivista
List of contributors:
De Freitas, Tt; Assanelli, A; Greco, R; Marktel, S; Vago, L; Carrabba, M; Lorentino, F; Bernardi, M; Forcina, A; Peccatori, J; Corti, C; Ciceri, F
Published in: